CA
SMTI icon

Clearstead Advisors’s Sanara MedTech SMTI Stock Holding History

Clearstead Advisors’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24 Buy
+1
New +$21 ﹤0.01% 3568

Other funds holding SMTI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
EFA
Evernest Financial Advisors Carmel, Indiana $478M AUM 24% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Clearstead Advisors's SMTI Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Sanara MedTech (SMTI) in Q2 2026: 1 share worth $24. The stake represents ﹤0.01% of the portfolio and ranks #3568 among its holdings.

27 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

  • Clearstead Advisors held 1 share of Sanara MedTech worth $24 as of Q2 2026.
  • Sanara MedTech was a new Clearstead Advisors position in Q2 2026.
  • Sanara MedTech made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3568 holding.
  • 27 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.